Current epidemiology of Staphylococcus aureus with decreased susceptibility to glycopeptides (vancomycin and teicoplanin) in France

Author(s): Allouch PY, Astagneau P, Aubry Damon H, Bismuth R, Brun Buisson C, Buu Hoi A, Carlet J, Chesneau O, Chaperon J, Courvalin P, Desenclos JC, Drucker J, Drugeon H, El Solh N, Etienne J, Fabry J, Gutmann L, Jarlier V, Joly C, Kac G, Leclercq R, Legrand P, Mainardi JL, Meunier O, Parneix P, Pierre V, Podglajen I, Ploy MC, Rauss A, Reverdy ME, Savey A, Soussy CJ, Struelens M, Tran B

Publishing year: 2000

In relation to

Our latest news

news

Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...

news

Andes Hantavirus: Implementation of epidemiological investigations and...

news

Call for Applications for the Renewal of the Editorial Board of the Weekly...